packageAlogliptin

alogliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alogliptin is a DPP-4 inhibitor used to lower blood glucose in adults with type 2 diabetes. It is authorised in the European Union and used as an oral anti-diabetic medicine, including in fixed-dose combinations with other glucose-lowering drugs.

Summary written by glm-5.3-flash from Wikidata Q4734170 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:alogliptin
ATC codes:A10BH04
DrugBank:DB06203
PubChem CID:11450633
ChEBI:72323
Wikidata:Q4734170
formula:C18H21N5O2
molar mass:339.399 g/mol (PubChem CID 11450633)
logP:0.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown